LAMB3 Promotes Intestinal Inflammation Through SERPINA3 and Is Directly Transcriptionally Regulated by P65 in Inflammatory Bowel Disease
Inflammatory Bowel Diseases · 2024
DOI: 10.1093/ibd/izad140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2024. Verfasst von Fangyuan Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Crohn Disease, Inflammatory Bowel Diseases, Serpins. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai, National Natural Science Foundation of China, Qingfeng Scientific Research Fund of the China Crohn's and Colitis Foundation.
Abstract (Originalsprache)
Background
Various extracellular matrix (ECM) reshaping events are involved in inflammatory bowel disease (IBD). LAMB3 is a vital subunit of laminin-332, an important ECM component. Data on the biological function of LAMB3 in intestinal inflammation are lacking. Our aim is to discuss the effect of LAMB3 in IBD.
Methods
LAMB3 expression was assessed in cultured intestinal epithelial cells, inflamed mucosal tissues of patients and mouse colitis models. RNA sequencing, quantitative real-time polymerase chain reaction and Western blotting were used to detect the LAMB3 expression distribution and potential downstream target genes. Dual-luciferase assays and chromatin immunoprecipitation-quantitative polymerase chain reaction were used to determine whether P65 could transcriptionally activate LAMB3 under tumor necrosis factor α stimulation.
Results
LAMB3 expression was increased in inflammatory states in intestinal epithelial cells and colonoids and was associated with adverse clinical outcomes in Crohn’s disease. Knockdown of LAMB3 inhibited the expression of proinflammatory cytokines. Mechanistically, LAMB3 expression was directly transcriptionally activated by P65 and was inhibited by nuclear factor kappa B inhibitors under tumor necrosis factor α stimulation. Furthermore, RNA sequencing and replenishment experiments revealed that LAMB3 upregulated SERPINA3 to promote intestinal inflammation via the integrin α3β1/FAK pathway.
Conclusion
We propose that LAMB3 could serve as a potential therapeutic target of IBD and a predictor of intestinal stenosis of Crohn’s disease. Our findings demonstrate the important role of ECM in the progression of IBD and offer an experimental basis for the treatment and prognosis of IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
- Department of Gastroenterology, Rui Jin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
ORCID-Profile: Peng Du
Förderung
- Natural Science Foundation of Shanghai
- National Natural Science Foundation of China
- Qingfeng Scientific Research Fund of the China Crohn's and Colitis Foundation
- Qingfeng Scientific Research Fund of the China Crohn’s and Colitis Foundation
Zitieren
APA
Liu, F., Xu, W., Wang, Y., Huang, Z., Zhu, Z., Ou, W., Tang, W., Fu, J., Liu, C., Gu, Y., Liu, Y., & Du, P. (2024). LAMB3 Promotes Intestinal Inflammation Through SERPINA3 and Is Directly Transcriptionally Regulated by P65 in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izad140
Vancouver
Liu F, Xu W, Wang Y, Huang Z, Zhu Z, Ou W, et al. LAMB3 Promotes Intestinal Inflammation Through SERPINA3 and Is Directly Transcriptionally Regulated by P65 in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 2024. doi:10.1093/ibd/izad140
BibTeX
@article{Liu2024,
author = {Liu, Fangyuan and Xu, Weimin and Wang, Yaosheng and Huang, Zhenyu and Zhu, Zhehui and Ou, Weijun and Tang, Wenbo and Fu, Jihong and Liu, Chenying and Gu, Yubei and Liu, Yun and Du, Peng},
title = {LAMB3 Promotes Intestinal Inflammation Through SERPINA3 and Is Directly Transcriptionally Regulated by P65 in Inflammatory Bowel Disease},
journal = {Inflammatory Bowel Diseases},
year = {2024},
doi = {10.1093/ibd/izad140}
}
EUVIMED